Literature DB >> 9740206

Use of probiotics in childhood gastrointestinal disorders.

J A Vanderhoof1, R J Young.   

Abstract

Probiotics appear to be useful in the prevention or treatment of several gastrointestinal disorders, including infectious diarrhea, antibiotic diarrhea, and traveler's diarrhea. Results of preliminary human and animal studies suggest that patients with inflammatory diseases, and even irritable bowel syndrome, may benefit from probiotic therapy. Probiotics represent an exciting therapeutic advance, although much investigation must be undertaken before their role in gastroenterology is clearly delineated. Questions related to probiotic origin, survivability, and adherence are all important considerations for further study. More important, each probiotic proposed must be studied individually and extensively to determine its efficacy and safety in each disorder for which its use may be considered.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9740206     DOI: 10.1097/00005176-199809000-00011

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  16 in total

1.  Combination therapy with Bifidobacterium breve, Lactobacillus casei, and galactooligosaccharides dramatically improved the intestinal function in a girl with short bowel syndrome: a novel synbiotics therapy for intestinal failure.

Authors:  Y Kanamori; K Hashizume; M Sugiyama; M Morotomi; N Yuki
Journal:  Dig Dis Sci       Date:  2001-09       Impact factor: 3.199

2.  Immunonutritional effects during synbiotics therapy in pediatric patients with short bowel syndrome.

Authors:  Keiichi Uchida; Takuya Takahashi; Mikihiro Inoue; Masami Morotomi; Kohei Otake; Makoto Nakazawa; Yoshihide Tsukamoto; Chikao Miki; Masato Kusunoki
Journal:  Pediatr Surg Int       Date:  2007-01-05       Impact factor: 1.827

3.  Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind, placebo-controlled trial.

Authors:  M Beausoleil; N Fortier; S Guénette; A L'ecuyer; M Savoie; M Franco; J Lachaine; K Weiss
Journal:  Can J Gastroenterol       Date:  2007-11       Impact factor: 3.522

Review 4.  Therapeutical use of probiotic formulations in clinical practice.

Authors:  T Iannitti; B Palmieri
Journal:  Clin Nutr       Date:  2010-06-23       Impact factor: 7.324

Review 5.  Acute gastroenteritis in children : what role for antibacterials?

Authors:  Nopaorn Phavichitr; Anthony Catto-Smith
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 6.  Probiotics for treating acute infectious diarrhoea.

Authors:  Stephen J Allen; Elizabeth G Martinez; Germana V Gregorio; Leonila F Dans
Journal:  Cochrane Database Syst Rev       Date:  2010-11-10

Review 7.  Gut microbiota imbalance and chaperoning system malfunction are central to ulcerative colitis pathogenesis and can be counteracted with specifically designed probiotics: a working hypothesis.

Authors:  Maurizio Bellavia; Giovanni Tomasello; Marcello Romeo; Provvidenza Damiani; Attilio I Lo Monte; Luciano Lozio; Claudia Campanella; Antonella Marino Gammazza; Francesca Rappa; Giovanni Zummo; Massimo Cocchi; Everly Conway de Macario; Alberto J L Macario; Francesco Cappello
Journal:  Med Microbiol Immunol       Date:  2013-07-18       Impact factor: 3.402

8.  Nondigestible oligosaccharides enhance bacterial colonization resistance against Clostridium difficile in vitro.

Authors:  Mark J Hopkins; George T Macfarlane
Journal:  Appl Environ Microbiol       Date:  2003-04       Impact factor: 4.792

9.  Functional and probiotic attributes of an indigenous isolate of Lactobacillus plantarum.

Authors:  Jai K Kaushik; Ashutosh Kumar; Raj K Duary; Ashok K Mohanty; Sunita Grover; Virender K Batish
Journal:  PLoS One       Date:  2009-12-01       Impact factor: 3.240

10.  Pouchitis in Children: Therapeutic Options.

Authors:  Jean Perrault
Journal:  Curr Treat Options Gastroenterol       Date:  2002-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.